US3919205A
(en)
|
1972-07-17 |
1975-11-11 |
Squibb & Sons Inc |
Dithiocarbonylthioacetyl cephalosporin derivatives
|
US5166331A
(en)
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
FR2654725B1
(fr)
|
1989-11-23 |
1992-02-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
US5420297A
(en)
|
1990-10-24 |
1995-05-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptides having substance P antagonistic activity
|
FR2676055B1
(fr)
|
1991-05-03 |
1993-09-03 |
Sanofi Elf |
Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
JPH0733386B2
(ja)
|
1991-05-31 |
1995-04-12 |
フアイザー・インコーポレイテツド |
キヌクリジン誘導体
|
GB9113219D0
(en)
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
JPH06509332A
(ja)
|
1991-07-05 |
1994-10-20 |
メルク シヤープ エンド ドーム リミテツド |
芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
EP0916346A3
(en)
|
1991-09-20 |
2000-12-06 |
Glaxo Group Limited |
NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
|
GB9200535D0
(en)
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
WO1993017032A1
(en)
|
1992-02-24 |
1993-09-02 |
The Trustees Of The University Of Pennsylvania |
Techniques and intermediates for preparing non-peptide peptidomimetics
|
FR2689889B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, et leur preparation.
|
TW241258B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
1992-04-15 |
1995-02-21 |
Takeda Pharm Industry Co Ltd |
|
US6048859A
(en)
|
1992-06-29 |
2000-04-11 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
US5719147A
(en)
|
1992-06-29 |
1998-02-17 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
IL111002A
(en)
|
1993-09-22 |
1998-09-24 |
Glaxo Group Ltd |
Piperidine derivatives their preparation and pharmaceutical compositions containing them
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
|
IL112778A0
(en)
|
1994-03-04 |
1995-05-26 |
Merck & Co Inc |
Substituted heterocycles, their preparation and pharmaceutical compositions containing them
|
FR2718136B1
(fr)
|
1994-03-29 |
1996-06-21 |
Sanofi Sa |
Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
|
CA2198382A1
(en)
|
1994-09-30 |
1996-04-11 |
Novartis Ag |
1-acyl-4-aliphatylaminopiperidine compounds
|
BR9607335A
(pt)
|
1995-02-22 |
1997-11-25 |
Novartis Ag |
Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1
|
GB9505692D0
(en)
|
1995-03-21 |
1995-05-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5886011A
(en)
|
1995-03-27 |
1999-03-23 |
Hisamitsu Pharmaceutical Co., Inc. |
Piperidine derivatives as substance P antagonists
|
DE19519245C2
(de)
|
1995-04-14 |
2003-04-30 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9510600D0
(en)
|
1995-05-25 |
1995-07-19 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives
|
TW382017B
(en)
|
1995-12-27 |
2000-02-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
|
DE19608665A1
(de)
|
1996-03-06 |
1997-09-11 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9625843D0
(en)
|
1996-12-12 |
1997-01-29 |
Merck & Co Inc |
Phenyl spiroethercycloalkyl tachykinn receptor antagonists
|
AU5239898A
(en)
|
1996-10-25 |
1998-05-15 |
Merck & Co., Inc. |
Phenyl spiroethercycloalkyl tachykinin receptor antagonists
|
US5929094A
(en)
|
1996-10-25 |
1999-07-27 |
Merck & Co., Inc. |
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
|
GB9700597D0
(en)
|
1997-01-14 |
1997-03-05 |
Sandoz Pharma Uk |
Organic compounds
|
JPH10259184A
(ja)
|
1997-03-18 |
1998-09-29 |
Takeda Chem Ind Ltd |
三環性複素環化合物の製造法
|
ZA985765B
(en)
|
1997-07-02 |
1999-08-04 |
Merck & Co Inc |
Polymorphic form of a tachykinin receptor antagonist.
|
HUP0003548A3
(en)
|
1997-08-06 |
2002-04-29 |
Lilly Co Eli |
2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
|
TW426667B
(en)
|
1997-11-19 |
2001-03-21 |
Pfizer |
Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
|
GB9905010D0
(en)
|
1999-03-04 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6291465B1
(en)
|
1999-03-09 |
2001-09-18 |
Hoffmann-La Roche Inc. |
Biphenyl derivatives
|
CO5150225A1
(es)
|
1999-03-19 |
2002-04-29 |
Merck Sharp & Dohme |
Derivados del tetrahidropirano y su uso como agentes terapeuticos
|
GB9907571D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Compounds
|
TR200103229T2
(tr)
|
1999-05-10 |
2002-04-22 |
Acordis Industrial Fibers Gmbh |
Filaman oluşturan poliesterler ve kopoliesterler ve bunların üretilmesi için bir işlem
|
JP3229294B2
(ja)
|
1999-06-04 |
2001-11-19 |
キヤノン販売株式会社 |
被成膜面の改質方法及び半導体装置の製造方法
|
EP1219619B1
(en)
|
1999-10-07 |
2004-08-11 |
Hisamitsu Pharmaceutical Co. Inc. |
3-amino-2-phenylpiperidine derivatives as substance p antagonists
|
GB9923748D0
(en)
|
1999-10-07 |
1999-12-08 |
Glaxo Group Ltd |
Chemical compounds
|
ATE400563T1
(de)
|
2000-04-06 |
2008-07-15 |
Astrazeneca Ab |
Neue neurokinin-antagonisten zum gebrauch als arzneimittel
|
ATE308513T1
(de)
|
2000-04-06 |
2005-11-15 |
|
Naphthamid-neurokinin antagonisten zur verwendung als medikamente
|
GB0012240D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1327997A
(zh)
|
2000-06-12 |
2001-12-26 |
上海博德基因开发有限公司 |
一种新的多肽——Ras GTP酶激活蛋白9.57和编码这种多肽的多核苷酸
|
DE10036818A1
(de)
|
2000-07-28 |
2002-02-07 |
Solvay Pharm Gmbh |
Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
|
PE20020444A1
(es)
|
2000-09-22 |
2002-06-14 |
Merck & Co Inc |
Antagonistas de receptores de taquiquinina zwitterionica
|
SE0003476D0
(sv)
|
2000-09-28 |
2000-09-28 |
Astrazeneca Ab |
Compounds
|
GB0025354D0
(en)
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
US6642226B2
(en)
|
2001-02-06 |
2003-11-04 |
Hoffman-La Roche Inc. |
Substituted phenyl-piperidine methanone compounds
|
GB0108595D0
(en)
|
2001-04-05 |
2001-05-23 |
Glaxo Group Ltd |
Chemical compounds
|
GB0114867D0
(en)
|
2001-06-18 |
2001-08-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0119797D0
(en)
|
2001-08-14 |
2001-10-03 |
Glaxo Group Ltd |
Chemical compounds
|
EP1295599A1
(en)
|
2001-09-21 |
2003-03-26 |
Boehringer Ingelheim International GmbH |
Method for the treatment of prevention of atopic dermatitis
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
ATE427310T1
(de)
|
2002-01-18 |
2009-04-15 |
Kyorin Seiyaku Kk |
Kondensierte bicyclische pyrimidinderivate
|
GB0203020D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2005522436A
(ja)
|
2002-02-08 |
2005-07-28 |
グラクソ グループ リミテッド |
ピペリジルカルボキシアミド誘導体またはそのタキキニン介在疾患の治療における使用
|
GB0203022D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2004002334A
(ja)
|
2002-03-25 |
2004-01-08 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
NZ535886A
(en)
|
2002-04-26 |
2007-07-27 |
Lilly Co Eli |
Triazole derivatives as tachykinin receptor antagonists
|
GB0215392D0
(en)
|
2002-07-03 |
2002-08-14 |
Glaxo Group Ltd |
Chemical compounds
|
WO2004005256A2
(en)
|
2002-07-03 |
2004-01-15 |
Glaxo Group Limited |
Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors
|
GB0217068D0
(en)
|
2002-07-23 |
2002-08-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0220953D0
(en)
|
2002-09-10 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
GB0310724D0
(en)
|
2003-05-09 |
2003-06-11 |
Glaxo Group Ltd |
Chemical compounds
|
WO2005019225A1
(ja)
|
2003-08-21 |
2005-03-03 |
Kyorin Pharmaceutical Co., Ltd. |
Nk1受容体拮抗作用を有する化合物の製造方法及びその製造中間体
|
TWI341198B
(en)
|
2004-01-27 |
2011-05-01 |
Merck Sharp & Dohme |
Hydroisoindoline tachykinin receptor antagonists
|
US8108430B2
(en)
|
2004-04-30 |
2012-01-31 |
Microsoft Corporation |
Carousel control for metadata navigation and assignment
|
GB0412865D0
(en)
|
2004-06-09 |
2004-07-14 |
Glaxo Group Ltd |
Chemical compounds
|
US20070293492A1
(en)
|
2004-12-03 |
2007-12-20 |
Devita Robert J |
Quinoline Tachykinin Receptor Antagonists
|
US20080039494A1
(en)
|
2004-12-03 |
2008-02-14 |
Jianming Bao |
8-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists
|
WO2006065711A2
(en)
|
2004-12-14 |
2006-06-22 |
Merck & Co., Inc. |
Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
|
US7354922B2
(en)
|
2004-12-14 |
2008-04-08 |
Schering Corporation |
Bridged ring NK1 antagonists
|
WO2006106727A1
(ja)
|
2005-03-31 |
2006-10-12 |
Nippon Zoki Pharmaceutical Co., Ltd. |
ベンジルオキシプロピルアミン誘導体
|
US20090048248A1
(en)
|
2005-12-22 |
2009-02-19 |
Devita Robert J |
Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists
|
WO2007074491A1
(en)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
|
JP2007277231A
(ja)
|
2006-03-16 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
US20090286777A1
(en)
|
2006-05-15 |
2009-11-19 |
Jianming Bao |
5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists
|
CA2667543A1
(en)
|
2006-10-26 |
2008-05-02 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical combinations for treatment of respiratory and gastrointestinal disorders
|
JP2008239618A
(ja)
|
2007-02-28 |
2008-10-09 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
CA2690737A1
(en)
|
2007-06-22 |
2008-12-31 |
Merck Sharp & Dohme Corp. |
6.5-pyrrolopiperidine tachykinin receptor antagonists
|
PL2260029T3
(pl)
*
|
2008-02-26 |
2015-03-31 |
Sandoz Ag |
Otrzymywanie pochodnych morfoliny
|
US20100098772A1
(en)
|
2008-10-21 |
2010-04-22 |
Allergan, Inc. |
Drug delivery systems and methods for treating neovascularization
|
ES2559475T3
(es)
|
2009-11-18 |
2016-02-12 |
Helsinn Healthcare Sa |
Composiciones para tratar náuseas y vómitos de origen central
|
KR102166277B1
(ko)
|
2013-04-12 |
2020-10-15 |
삼성전자주식회사 |
무선 통신 네트워크를 이용한 운전 지원 방법 및 장치와 그 시스템
|
US11915196B2
(en)
|
2019-05-23 |
2024-02-27 |
Capital One Services, Llc |
Self-service lender portal
|